These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23734707)

  • 81. Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D.
    Krześniak M; Zajkowicz A; Matuszczyk I; Rusin M
    Mech Ageing Dev; 2014 Jul; 139():11-21. PubMed ID: 24915467
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The C terminus of p53 family proteins is a cell fate determinant.
    Harms KL; Chen X
    Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
    [TBL] [Abstract][Full Text] [Related]  

  • 83. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
    Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
    Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.
    Kong B; Cheng T; Qian C; Wu W; Steiger K; Cao J; Schlitter AM; Regel I; Raulefs S; Friess H; Erkan M; Esposito I; Kleeff J; Michalski CW
    Mol Cancer; 2015 Dec; 14():212. PubMed ID: 26683340
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Transcription factors CEP-1/p53 and CEH-23 collaborate with AAK-2/AMPK to modulate longevity in Caenorhabditis elegans.
    Chang HW; Pisano S; Chaturbedi A; Chen J; Gordon S; Baruah A; Lee SS
    Aging Cell; 2017 Aug; 16(4):814-824. PubMed ID: 28560849
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype.
    Gottschalk B; Klein A
    Mol Cell Biochem; 2013 Jul; 379(1-2):213-27. PubMed ID: 23564067
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Metastatic role of mammalian target of rapamycin signaling activation by chemoradiotherapy in advanced rectal cancer.
    Shiratori H; Kawai K; Okada M; Nozawa H; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Kaneko M; Murono K; Emoto S; Ishii H; Sonoda H; Ushiku T; Ishihara S
    Cancer Sci; 2020 Apr; 111(4):1291-1302. PubMed ID: 31997546
    [TBL] [Abstract][Full Text] [Related]  

  • 88. NUDT22 promotes cancer growth through pyrimidine salvage.
    Walter M; Mayr F; Hanna BMF; Cookson V; Mortusewicz O; Helleday T; Herr P
    Oncogene; 2023 Apr; 42(16):1282-1293. PubMed ID: 36871087
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The chromatin-binding domain of Ki-67 together with p53 protects human chromosomes from mitotic damage.
    Garwain O; Sun X; Iyer DR; Li R; Zhu LJ; Kaufman PD
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34353903
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity.
    Prins S; Langron E; Hastings C; Hill EJ; Stefan AC; Griffin LD; Vergani P
    J Biol Chem; 2020 Dec; 295(49):16529-16544. PubMed ID: 32934006
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH
    Zhang X; Liu T; Li Z; Feng Y; Corpe C; Liu S; Zhang J; He X; Liu F; Xu L; Shen L; Li S; Xia Q; Peng X; Zhou X; Chen W; Zhang X; Xu J; Wang J
    Theranostics; 2019; 9(26):8109-8126. PubMed ID: 31754384
    [No Abstract]   [Full Text] [Related]  

  • 92. Identification of p53 Activators in a Human Microarray Compendium.
    Corton JC; Witt KL; Yauk CL
    Chem Res Toxicol; 2019 Sep; 32(9):1748-1759. PubMed ID: 31397557
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Post-translational regulation of p53 function through 20S proteasome-mediated cleavage.
    Solomon H; Bräuning B; Fainer I; Ben-Nissan G; Rabani S; Goldfinger N; Moscovitz O; Shakked Z; Rotter V; Sharon M
    Cell Death Differ; 2017 Dec; 24(12):2187-2198. PubMed ID: 28885617
    [TBL] [Abstract][Full Text] [Related]  

  • 94. p53, a translational regulator: contribution to its tumour-suppressor activity.
    Marcel V; Catez F; Diaz JJ
    Oncogene; 2015 Oct; 34(44):5513-23. PubMed ID: 25728674
    [TBL] [Abstract][Full Text] [Related]  

  • 95. ΔNp53 and aging.
    Lin SC; Taatjes DJ
    Aging (Albany NY); 2013 Oct; 5(10):717-8. PubMed ID: 24145197
    [No Abstract]   [Full Text] [Related]  

  • 96. The human ΔNp53 isoform triggers metabolic and gene expression changes that activate mTOR and alter mitochondrial function.
    Lin SC; Karoly ED; Taatjes DJ
    Aging Cell; 2013 Oct; 12(5):863-72. PubMed ID: 23734707
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
    Levandowski CB; Jones T; Gruca M; Ramamoorthy S; Dowell RD; Taatjes DJ
    PLoS Biol; 2021 Aug; 19(8):e3001364. PubMed ID: 34351910
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos.
    Davidson WR; Kari C; Ren Q; Daroczi B; Dicker AP; Rodeck U
    BMC Dev Biol; 2010 Oct; 10():102. PubMed ID: 20929554
    [TBL] [Abstract][Full Text] [Related]  

  • 99. DeltaNp53 or p44: priming the p53 pump.
    Scrable H; Sasaki T; Maier B
    Int J Biochem Cell Biol; 2005 May; 37(5):913-9. PubMed ID: 15743665
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.